Literature DB >> 6180070

Properties of a human alpha-interferon purified from E. coli extracts.

R Wetzel, L J Perry, D A Estell, N Lin, H L Levine, B Slinker, F Fields, M J Ross, J Shively.   

Abstract

A human alpha interferon, designated HuIFN-alpha A, produced in E. coli by direct expression of cloned cDNA [Goeddel et al., Nature 287, 411--416 (1980)] has been purified from bacterial extracts and characterized. The protein has a molecular weight (19,400 by SDS/PAGE) and amino acid composition consistent with the DNA sequence. The pI was determined to be 6.1. The molecule has a specific activity of 1.5 x 10(8) NIH reference units/mg of protein. The sequence of the first 35 amino acids is identical to that expected from the nucleotide sequence. About 50% of the molecules begin with the expected cysteine, and 50% begin with the initiator methionine which E. coli apparently did not remove efficiently. Analysis of a trypsin digest of the native molecule showed that all four of the molecule's cysteines are involved in disulfide bonds: Cys1 is bonded to Cys98, and Cys29 is bonded to Cys 138.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6180070     DOI: 10.1089/jir.1981.1.381

Source DB:  PubMed          Journal:  J Interferon Res        ISSN: 0197-8357


  9 in total

1.  A few distinct 'molecular sandwiches' are basis for structural and functional similarities of subspecies of interferon alpha and of families of growth-promoting hormones.

Authors:  A D Inglot; W Popik; E Piasecki; J Czyrski
Journal:  Mol Biol Rep       Date:  1986       Impact factor: 2.316

2.  Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta, and gamma interferons.

Authors:  C W Czarniecki; C W Fennie; D B Powers; D A Estell
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

3.  Adenovirus early region 1A modulation of interferon antiviral activity.

Authors:  K P Anderson; E H Fennie
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

4.  Site-specific mutagenesis of the human fibroblast interferon gene.

Authors:  D F Mark; S D Lu; A A Creasey; R Yamamoto; L S Lin
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

5.  Antiviral activities of hybrids of two major human leukocyte interferons.

Authors:  P K Weck; S Apperson; N Stebbing; P W Gray; D Leung; H M Shepard; D V Goeddel
Journal:  Nucleic Acids Res       Date:  1981-11-25       Impact factor: 16.971

6.  Antiviral activity of bacteria-derived human alpha interferons against encephalomyocarditis virus infection of mice.

Authors:  P K Weck; E Rinderknecht; D A Estell; N Stebbing
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

7.  The construction of a synthetic Escherichia coli trp promoter and its use in the expression of a synthetic interferon gene.

Authors:  J D Windass; C R Newton; J De Maeyer-Guignard; V E Moore; A F Markham; M D Edge
Journal:  Nucleic Acids Res       Date:  1982-11-11       Impact factor: 16.971

Review 8.  Interferon induction and function at the mucosal surface.

Authors:  Russell K Durbin; Sergei V Kotenko; Joan E Durbin
Journal:  Immunol Rev       Date:  2013-09       Impact factor: 12.988

9.  Failure of high doses of alpha interferon to affect the growth of human carcinoma, melanoma, and myeloid leukaemia xenografts.

Authors:  R D Clutterbuck; J L Millar; P Alexander
Journal:  Br J Cancer       Date:  1983-09       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.